HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

No winner of Lotto jackpot

Kevin Mallon release on bail delayed due to 'lack of ankle tags'

Three men to appear in Cork court following drug seizures made on Thursday

Firearms seized in Dublin search operation


Today's Stories

Government talks with web giants on tackling extremism on social media

Two patients a day seek treatment in EU over failings in our health system

McDonald’s opposes Supermac’s overseas expansion plans again

Courthouse authorities may be compelled to ensure full access

Lifestyle

Irish wool textile weaving is alive and thriving

Welsh Rarebit: The perfect cheese on toast recipe, for tea time

Make your garden a musical haven, with help from green-fingered DJ Jo Whiley

Robin Gill’s Garden Courgette with Smoked Buffalo Milk Curd and Roof-Top Honey

More From The Irish Examiner